Higher Pulse Pressure Is Associated With Increased Risk of Cardio-cerebrovascular Disease and All-Cause Mortality: A Korean National Cohort Study

被引:4
|
作者
Lee, Jae-Woo [1 ]
Shin, Sang-Jun [2 ]
Kim, Joungyoun [3 ]
Kang, Hee-Taik [1 ,4 ]
机构
[1] Chungbuk Natl Univ Hosp, Dept Family Med, Cheongju, South Korea
[2] Chungbuk Natl Univ, Dept Informat & Stat, Cheongju, South Korea
[3] Yonsei Univ, Coll Nursing, Mo Im Kim Nursing Res Inst, Dept Nursing, Seoul, South Korea
[4] Chungbuk Natl Univ, Dept Family Med, Coll Med, Cheongju, Chungbuk, South Korea
基金
新加坡国家研究基金会;
关键词
blood pressure; cardiovascular disease; cerebrovascular disease; hypertension; pulse pressure; systolic blood pressure; SYSTOLIC BLOOD-PRESSURE; NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; CARDIOVASCULAR MORTALITY; ARTERIAL STIFFNESS; HYPERTENSION; ADULTS; PREVALENCE; PREVENTION; HEALTH;
D O I
10.1093/ajh/hpac043
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND This study aimed to investigate the association of pulse pressure (PP) with the cardio-cerebrovascular disease (CCVD) risk and all-cause mortality according to blood pressure level using Korean national cohort data. METHODS This study was retrospectively designed and based on the Korean National Health Insurance Service-National Health Screening Cohort. Participants aged 40-69 years at baseline were categorized into normal, elevated, stage 1, and stage 2 groups according to blood pressure. Each group was further classified into 5 groups separated by 10-mm Hg increments in PP. The primary composite outcome was defined as CCVDs and all-cause mortality. Cox proportional hazards regression models were adopted after stepwise adjustment for confounders to investigate the composite outcome. RESULTS During the follow-up period (median follow-up period, 12.0 years), the primary composite outcome occurred in 18,444 (15.0%) of 122,783 men and 10,096 (11.4%) of 88,550 women. After complete adjustment for confounders, in the stage 1 hypertensive men, the hazard ratio (95% confidence intervals [CIs]) of the 31-40, 41-50, 51-60, and >60 mm Hg PP groups was 1.112 (1.013-1.221), 1.035 (0.942-1.137), 1.009 (0.907-1.123), and 1.324 (1.130-1.551) in comparison with the <= 30 mm Hg PP group. In the stage 2 hypertensive men, the HRs (95% CIs) were 1.069 (0.949-1.204), 1.059 (0.940-1.192), 1.123 (0.999-1.263), and 1.202 (1.061-1.358) compared to the <= 30 mm Hg PP group. However, these associations were not significant in women. CONCLUSIONS Hypertensive men with an increased PP have an increased risk of CCVDs and all-cause mortality.
引用
收藏
页码:647 / 655
页数:9
相关论文
共 50 条
  • [31] Frequency of adding salt at the table and risk of incident cardiovascular disease and all-cause mortality: a prospective cohort study
    Li, Fengping
    Chen, Liangkai
    Liu, Buyun
    Zhong, Victor W. W.
    Deng, Yan
    Luo, Dan
    Gao, Chao
    Bao, Wei
    Rong, Shuang
    BMC MEDICINE, 2022, 20 (01)
  • [32] The associations of blood pressure parameters with all-cause and cardiovascular mortality in peritoneal dialysis patients: a cohort study in China
    Xie, Xishao
    Lv, Duo
    Zheng, Haiyan
    Zhang, Xiaohui
    Han, Fei
    Chen, Jianghua
    JOURNAL OF HYPERTENSION, 2020, 38 (11) : 2252 - 2260
  • [33] Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study
    Hutchinson, Moira Strand
    Grimnes, Guri
    Joakimsen, Ragnar Martin
    Figenschau, Yngve
    Jorde, Rolf
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (05) : 935 - 942
  • [34] Blood Pressure on Ambulatory Monitoring and Risk for Cardiovascular Disease and All-Cause Mortality: Ecological Validity or Measurement Reliability?
    Tanner, Rikki M.
    Jaeger, Byron C.
    Bradley, Corey K.
    Thomas, S. Justin
    Min, Yuan-, I
    Hardy, Shakia T.
    Irvin, Marguerite Ryan
    Shimbo, Daichi
    Schwartz, Joseph E.
    Muntner, Paul
    AMERICAN JOURNAL OF HYPERTENSION, 2024, : 111 - 119
  • [35] Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: A prospective cohort study
    Amberbir, Alemayehu
    Banda, Victor
    Singano, Victor
    Matengeni, Alfred
    Pfaff, Colin
    Ismail, Zahra
    Allain, Theresa J.
    Chan, Adrienne K.
    Sodhi, Sumeet K.
    van Oosterhout, Joep J.
    PLOS ONE, 2019, 14 (01):
  • [36] Blood Pressure and Risk of All-Cause Mortality in Advanced Chronic Kidney Disease and Hemodialysis The Chronic Renal Insufficiency Cohort Study
    Bansal, Nisha
    McCulloch, Charles E.
    Rahman, Mahboob
    Kusek, John W.
    Anderson, Amanda H.
    Xie, Dawei
    Townsend, Raymond R.
    Lora, Claudia M.
    Wright, Jackson
    Go, Alan S.
    Ojo, Akinlolu
    Alper, Arnold
    Lustigova, Eva
    Cuevas, Magda
    Kallem, Radhakrishna
    Hsu, Chi-Yuan
    HYPERTENSION, 2015, 65 (01) : 93 - +
  • [37] Low Diastolic Blood Pressures Are Associated With an Increased Risk of Myocardial Infarction, Peripheral Arterial Disease, and All-Cause Mortality, but Not Cerebrovascular Accident - A Reanalysis of ALLHAT
    Itoga, Nathan K.
    Tawfik, Daniel S.
    Lee, Charles K.
    Maruyama, Satoshi
    Leeper, Nicholas J.
    Chang, Tara I.
    CIRCULATION, 2017, 136
  • [38] Effects of dietary patterns on the all-cause mortality and cardiovascular disease mortality in patients with hypertension: A cohort study based on the NHANES database
    Li, Fang
    Zhang, Yanping
    Pan, Lina
    Chen, Hui
    CLINICAL CARDIOLOGY, 2023, 46 (11) : 1353 - 1370
  • [39] Lifestyle Changes in Young Adulthood and Middle Age and Risk of Cardiovascular Disease and All-Cause Mortality: The Doetinchem Cohort Study
    Hulsegge, Gerben
    Looman, Moniek
    Smit, Henriette A.
    Daviglus, Martha L.
    van der Schouw, Yvonne T.
    Verschuren, W. M. Monique
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (01):
  • [40] Estimated Pulse Wave Velocity Is Associated With All-Cause Mortality and Cardiovascular Mortality Among Adults With Chronic Kidney Disease
    Feng, Xiao-Hua
    Chen, Yi
    Chen, Xue-Qi
    Zhao, Wei-Hong
    JOURNAL OF CLINICAL HYPERTENSION, 2025, 27 (01)